Market overview
The global drug store market is worth USD 1.4 tn in 2026 and is forecast to reach USD 2.1 tn by 2036, growing at a 4.5% CAGR. United States is the largest country market and Prescription medicines is the largest by category segment.
| Scope | Retail sales of drug stores and pharmacy chains, covering prescription medicines, over-the-counter products, health and beauty, and convenience goods. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.3 tn |
| Value 2026 | USD 1.4 tn |
| Value 2036 | USD 2.1 tn |
| CAGR 2026-2036 | 4.5% |
| Volume 2026 | 461 thousand stores |
| Volume 2036 | 587 thousand stores |
| Average price 2026 | USD 2,947,000 per store |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Drug Store market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1,358 bn |
| 2027 | USD 1,420 bn |
| 2028 | USD 1,484 bn |
| 2029 | USD 1,550 bn |
| 2030 | USD 1,620 bn |
| 2031 | USD 1,693 bn |
| 2032 | USD 1,769 bn |
| 2033 | USD 1,849 bn |
| 2034 | USD 1,932 bn |
| 2035 | USD 2,019 bn |
| 2036 | USD 2,110 bn |
Drug Store market segmentation
By category
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Prescription medicines | 54.0% | 54.6% | USD 734 bn | 4.6% |
| Over-the-counter and wellness | 16.0% | 16.2% | USD 217 bn | 4.6% |
| Health and beauty | 18.0% | 18.2% | USD 245 bn | 4.6% |
| Convenience and other | 12.0% | 11.0% | USD 163 bn | 3.6% |
By channel
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Chain stores | 58.0% | 61.1% | USD 788 bn | 5.0% |
| Independent stores | 30.0% | 27.4% | USD 408 bn | 3.5% |
| Franchise and cooperative stores | 12.0% | 11.5% | USD 163 bn | 4.0% |
By payment source
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Out-of-pocket | 46.0% | 45.0% | USD 625 bn | 4.3% |
| Private insurance | 24.0% | 24.0% | USD 326 bn | 4.5% |
| Government-reimbursed | 30.0% | 31.0% | USD 408 bn | 4.8% |
By fulfilment mode
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| In-store purchase | 68.0% | 58.0% | USD 924 bn | 2.9% |
| Click-and-collect | 12.0% | 16.0% | USD 163 bn | 7.5% |
| Home delivery | 20.0% | 26.0% | USD 272 bn | 7.3% |
By store location
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Urban | 54.0% | 52.0% | USD 734 bn | 4.1% |
| Suburban | 30.0% | 30.0% | USD 408 bn | 4.5% |
| Rural and transport hubs | 16.0% | 18.0% | USD 217 bn | 5.7% |
Top 25 countries for drug store by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 84.0% of 2026 revenue and the 25 countries below together hold 96.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 408 bn | 30.0% | USD 591 bn | 3.8% |
| 2 | China | USD 217 bn | 16.0% | USD 401 bn | 6.3% |
| 3 | Japan | USD 122 bn | 9.0% | USD 160 bn | 2.8% |
| 4 | Germany | USD 81.5 bn | 6.0% | USD 112 bn | 3.2% |
| 5 | India | USD 67.9 bn | 5.0% | USD 158 bn | 8.8% |
| 6 | United Kingdom | USD 54.3 bn | 4.0% | USD 75.9 bn | 3.4% |
| 7 | France | USD 54.3 bn | 4.0% | USD 71.7 bn | 2.8% |
| 8 | Brazil | USD 54.3 bn | 4.0% | USD 94.9 bn | 5.7% |
| 9 | Canada | USD 40.8 bn | 3.0% | USD 59.1 bn | 3.8% |
| 10 | Italy | USD 40.8 bn | 3.0% | USD 52.7 bn | 2.6% |
| 11 | Spain | USD 17.5 bn | 1.3% | USD 24.5 bn | 3.4% |
| 12 | Mexico | USD 15.5 bn | 1.1% | USD 27.2 bn | 5.8% |
| 13 | Australia | USD 15.5 bn | 1.1% | USD 21.7 bn | 3.5% |
| 14 | South Korea | USD 15.5 bn | 1.1% | USD 21.7 bn | 3.5% |
| 15 | Russia | USD 13.6 bn | 1.0% | USD 19.0 bn | 3.4% |
| 16 | Turkey | USD 11.7 bn | 0.9% | USD 20.3 bn | 5.7% |
| 17 | Netherlands | USD 9.6 bn | 0.7% | USD 13.5 bn | 3.4% |
| 18 | Poland | USD 9.6 bn | 0.7% | USD 13.5 bn | 3.4% |
| 19 | Indonesia | USD 9.6 bn | 0.7% | USD 20.3 bn | 7.7% |
| 20 | Taiwan | USD 9.6 bn | 0.7% | USD 13.5 bn | 3.4% |
| 21 | Saudi Arabia | USD 7.7 bn | 0.6% | USD 13.5 bn | 5.7% |
| 22 | Thailand | USD 7.7 bn | 0.6% | USD 13.5 bn | 5.7% |
| 23 | Belgium | USD 7.7 bn | 0.6% | USD 10.8 bn | 3.3% |
| 24 | Argentina | USD 5.8 bn | 0.4% | USD 8.2 bn | 3.5% |
| 25 | Egypt | USD 5.8 bn | 0.4% | USD 10.1 bn | 5.7% |
| Rest of world | USD 54.6 bn | 4.0% | USD 82.1 bn | 4.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- CVS Health
- Walgreens Boots Alliance
- Boots
- A.S. Watson Group
- PHOENIX group
Group 2: Regional and specialist players
- Welcia Holdings
- Tsuruha Holdings
- Matsukiyo Cocokara
- dm-drogerie markt
- Rossmann
- Shoppers Drug Mart
- Sugi Holdings
- Raia Drogasil
- Clicks Group
- Dis-Chem
Group 3: Emerging and niche players
- Apollo Pharmacy
- Yifeng Pharmacy
- Dashenlin
- Tata 1mg
- PharmEasy
- MedPlus Health Services
- DocMorris
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the drug store market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 4.5% is calculated from the resulting values.
The market is divided by category, by channel, by payment source, by fulfilment mode, by store location. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the drug store market?
The global drug store market is estimated at USD 1.3 tn in 2025 and USD 1.4 tn in 2026.
How fast will the drug store market grow?
It is forecast to reach USD 2.1 tn by 2036, a compound annual growth rate of 4.5% from 2026, an increase of USD 751 bn.
Which country is the largest market for drug store?
United States is the largest market by revenue at USD 408 bn in 2026, 30.0% of the global total. The three largest countries together hold 55.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 8.8% a year from 2026 to 2036.
Which drug store segment is largest?
In the by category split, Prescription medicines is the largest segment with 54.0% of 2026 revenue.
Who are the leading drug store companies?
Global leaders include CVS Health, Walgreens Boots Alliance, Boots, A.S. Watson Group.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Pharmaceutical DistributionUSD 1.6 tn · 5.5% CAGR
- PharmaceuticalsUSD 1.8 tn · 6.0% CAGR
- Long Term CareUSD 1.0 tn · 5.5% CAGR
- Small Molecule DrugsUSD 1.0 tn · 5.0% CAGR
- PharmacyUSD 2.0 tn · 5.0% CAGR
- Health InsuranceUSD 2.5 tn · 6.0% CAGR
- Medical DevicesUSD 675 bn · 5.5% CAGR
- TabletUSD 580 bn · 5.5% CAGR